Talk:Myeloid-derived suppressor cell

2013 copyright ?
Hi, as this article is being majorly restructured, I did not put a speedy delete on it, but please be aware that copyright infringement is not allowed, and this article will be quickly deleted if the infringement remains. Also, please consider whether the article subject is notable enough to warrant an article, or again it may be quickly deleted. Good luck, Benboy00 (talk) 15:57, 17 September 2013 (UTC)

Clarify where they are found
Where do they differentiate ? Are they found in blood or only after infiltrating tumours ? Are they found in healing wounds ? - Rod57 (talk) 10:12, 28 March 2017 (UTC)
 * Apparently found in blood (of patients with cancer and other inflammatory pathologies) and tumour microenvironment. - Rod57 (talk) 13:46, 8 August 2018 (UTC)

/Myeloid-derived Suppressor Cell listed at Redirects for discussion
An editor has asked for a discussion to address the redirect /Myeloid-derived Suppressor Cell. Please participate in the redirect discussion if you wish to do so. UnitedStatesian (talk) 14:57, 10 April 2019 (UTC)

topic in lead not explained in rest of article
Lead says "The size of the myeloid suppressor compartment is considered to be an important factor in the clinical success or failure of cancer immunotherapy, highlighting the importance of this cell type for human pathophysiology.[7]" but this is not explained (eg what is "compartment") in the rest of the article. Perhaps this sentence should be moved to a new Clinical significance section ? - Rod57 (talk) 19:29, 27 September 2021 (UTC)

Leukemia and its connection to these cells
The connection to leukemia might be worthwhile explaining in a section dedicated exclusively to this particular cancer type as it is very relevant to its progression. — Preceding unsigned comment added by AMaser (talk • contribs) 16:25, 3 December 2021 (UTC)